Health SwifTech

THE CHALLENGES

The rise of antimicrobial-resistant pathogens, such as carbapenem-resistant Enterobacterales (CRE) and Candida auris, poses a significant challenge. MDR pathogens are increasingly prevalent in healthcare settings, exacerbated by the COVID-19 pandemic, which strained infection control measures and increased antibiotic misuse.

Detecting and tracking these pathogens requires advanced molecular detection methods, which are not uniformly available globally.

THE FACT

Antibiotic Resistance causes 1 death every 15 minutes in the world

Antibiotic resistance causes 1 death every 15 minutes in the world

Misdiagnosis drives antibiotic misuse, accelerating antimicrobial resistance (AMR), which already causes 700,000 deaths annually. Without improved diagnostics, AMR deaths could reach 10 million annually by 2050, becoming a top global killer.
Sepsis causes 11 million deaths yearly, largely due to delays in identifying infectious agents. This diagnostic gap increases mortality and the economic burden of treating advanced cases.
Misdiagnosis delays public health responses to outbreaks, especially zoonotic diseases, hampering surveillance and control. These delays worsen outbreaks, causing widespread illness and millions of preventable cases annually.

AMR has significantly increased Healthcare Costs and Productivity Losses

In the European Union, AMR leads to an estimated 2.5 million extra hospital days annually, resulting in approximately €1.5 billion in additional healthcare costs and productivity losses each year.

Approximately one in three bacteria associated with HAIs are resistant to antibiotics.This high resistance rate contributes to prolonged hospital stays and increased mortality.

Certain groups, such as patients undergoing cancer therapy, those with weakened immune systems, individuals on dialysis, and patients undergoing complex surgeries, are at a higher risk of contracting drug-resistant infections.

Bacteria: Hidden Challenges in Everyday Life

They spread between patients and staff, complicating treatment.
Spread locally and internationally through transport.
Spread through daily activities and shared environments.
Present in all types of food.

AccuGen™: Pioneering Precision NGS Diagnostics to Combat AMR (Antimicrobial Resistance).

The use of Next-Generation Sequencing (NGS) for infectious detection is crucial for antimicrobial resistance (AMR) management as it enables rapid identification of resistance genes, facilitating timely treatment decisions and enhancing surveillance efforts to monitor and control the spread of resistant pathogens globally.

OUR SOLUTIONS

AccuGen™ High-throughput Solutions can assist in the rapid measurement and acquisition of pathogen and drug resistance information from clinical infection samples.

AccuGen™ High-throughput Solutions is the optimal solution for detection of pathogenic microorganisms.

With AccuGen™ High-throughput Solutions , rapid pathogen identification and drug resistance gene detection can be realized through nucleic acid sequence detection of pathogenic microorganisms.

AccuGen™ High-throughput Solutions enables hospitals or institutions to easily achieve rapid and effective pathogen diagnosis through the localized deployment of mNGS and tNGS.

AccuGen™: Pioneering Precision NGS Diagnostics to Combat AMR (Antimicrobial Resistance).

AccuGen™: Full-Process Reagents for mNGS & tNGS

Independently Developed, Personalized and Intelligent Custom Bioinformatics Analysis Software

Health SwifTech developed the intelligent report analysis system, a visual and interactive report delivery system tailored to the needs of the customer and product characteristics.

Respiratory infection
Pediatric infectious diseases
Central nervous system infection
Others ：gastrointestinal infection/urinary tract infection /immunodeficiency

AccuGen™ offers an exceptional solution for precisely targeting infectious disease pathogens

Learn more